Staph infections carry long-term risks

Patients who harbor the highly contagious bacterium causing staph infections can develop serious and sometimes deadly symptoms a year or longer after initial detection, a UC Irvine infectious disease researcher has found.

A study led by Dr. Susan Huang shows that almost one-quarter of the patients who acquire the antibiotic-resistant bacterium MRSA (Methicillin-resistant Staphylococcus aureus) developed staph infections at least a year after initial detection. The infections included pneumonia and blood diseases, some of which were linked to deaths.

The most serious staph infections begin in hospitals or other healthcare settings, such as nursing homes and dialysis centers. The study is the first to show such long-term risk of these infections and point to the need for new treatment approaches. Results appear in the July 15 issue of Clinical Infectious Diseases.

“Since infection risk remains substantial among long-term carriers of MRSA, these patients should be targeted for interventions along with patients who newly acquire MRSA,” said Huang, the epidemiology and infection prevention director at UC Irvine Medical Center.

Huang and Rupak Datta from Harvard Medical School followed 281 patients who had been MRSA-positive for anywhere from one to four years. Twenty-four percent developed invasive disease in the follow-up year, with pneumonia being the most common infection. MRSA was identified as a contributor to the deaths of 14 patients.

Staph infections can cause life-threatening skin infections, as well as infections in bones, joints, surgical wounds, heart valves and lungs. Older adults and people with weakened immune systems are at highest risk, although staph infections regularly occur in otherwise healthy people who are hospitalized.

MRSA is resistant to most antibiotics, but can be treated with vancomycin. Published studies show that approximately 2 percent of persons in the community and up to 5 percent to 8 percent of hospitalized patients harbor MRSA. The Centers for Disease Control and Prevention recommend that patients with MRSA be placed in single rooms and that medical staff wear gowns and gloves while caring for them to prevent spreading MRSA among patients.

“The severity of illness associated with MRSA in hospitalized patients urges us to identify the best way to reduce risks of infection,” Huang said. “Active research is ongoing to determine the safest and most effective intervention for different types of patients. Options include various antibiotic treatments, bathing agents and a hope for an effective vaccine.”

An assistant professor of medicine, Huang was an infectious diseases physician at Brigham & Women’s Hospital in Boston and an assistant professor at Harvard Medical School when the study was conducted. She joined UC Irvine in 2007.

Source: University of California, Irvine

Related stories:

Multi-tasking maggots in superbug showdown
Scientists at Swansea University (Wales, UK) have discovered a new type of antibiotic in maggot secretions that can tackle up to 12 different strains of MRSA, as well as E. coli and C. difficile. The research was funded by leading charity Action Medical Research, with support from the Rosetrees Trust.
Study shows sharp national rise in skin infections, MRSA suspected
A national analysis of physician office and emergency department records shows that the types of skin infections caused by community-acquired MRSA doubled in the eight-year study period, with the highest rates seen among children and in urban emergency rooms.
Breakthrough in the fight against deadly superbug
(PhysOrg.com) -- The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.
Online courses boost infection control skills that could prove vital in a pandemic
Online courses are helping staff to develop the skills they need to tackle hospital-acquired infections, such as MRSA and C.difficile, and this expertise could also prove vital in a pandemic, according to a study published in the latest issue of the UK-based Journal of Advanced Nursing.
Being an MRSA carrier increases risk of infection and death
Patients harboring methicillin-resistant Staphylococcus aureus (MRSA) for long periods of time continue to be at increased risk of MRSA infection and death, according to a new study in the July 15 issue of Clinical Infectious Diseases, currently available online.
Overcrowding and understaffing in hospitals increases levels of MRSA infections
A review article authored by a University of Queensland academic has found overcrowding and understaffing in hospitals are two key factors in the transmission of MRSA (Meticillin – Resistant Staphylococcus Aureus) infections worldwide.
Less hype and more research needed into new 'superbug,' say experts
Recent tabloid hype over the "newly emerging superbug", Stenotrophomonas maltophilia, is misplaced, say experts in this week's issue of the BMJ.
Can we 'wipe out' MRSA?
Three basic principles is all it could take to reduce the incidence of MRSA in hospitals according to a new research by Cardiff University.

News discussion:

Medicine & Health news